Premier Health of America 配当金

配当金基準チェック /06

Premier Health of America配当金を支払った記録がありません。

主要情報

n/a

配当利回り

-0.2%

バイバック利回り

総株主利回り	-0.2%
将来の配当利回り	n/a
配当成長	n/a
次回配当支払日	n/a
配当落ち日	n/a
一株当たり配当金	n/a
配当性向	n/a

最近の配当金アップデート

更新なし

Recent updates

Does Premier Health of America (CVE:PHA) Have A Healthy Balance Sheet?

Aug 20

Investors Aren't Entirely Convinced By Premier Health of America Inc.'s (CVE:PHA) Revenues

Jun 27

Premier Health of America (CVE:PHA) Has A Somewhat Strained Balance Sheet

May 02

A Piece Of The Puzzle Missing From Premier Health of America Inc.'s (CVE:PHA) 30% Share Price Climb

Feb 14

Further Upside For Premier Health of America Inc. (CVE:PHA) Shares Could Introduce Price Risks After 26% Bounce

Dec 28

Here's Why Premier Health of America (CVE:PHA) Has A Meaningful Debt Burden

Dec 12

These 4 Measures Indicate That Premier Health of America (CVE:PHA) Is Using Debt Extensively

Jul 06

Investors Shouldn't Be Too Comfortable With Premier Health of America's (CVE:PHA) Robust Earnings

May 28

Independent Chairman of the Board Eric Chouinard Just Bought 9.4% More Shares In Premier Health of America Inc. (CVE:PHA)

Feb 23

These 4 Measures Indicate That Premier Health of America (CVE:PHA) Is Using Debt Reasonably Well

Feb 08

決済の安定と成長

配当データの取得

安定した配当: PHAの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。

増加する配当: PHAの配当金が増加しているかどうかを判断するにはデータが不十分です。

配当利回り対市場

Premier Health of America 配当利回り対市場

PHA 配当利回りは市場と比べてどうか？
セグメント	配当利回り
会社 (PHA)	n/a
市場下位25% (CA)	1.8%
市場トップ25% (CA)	6.1%
業界平均 (Healthcare)	3.7%
アナリスト予想 (PHA) (最長3年)	n/a

注目すべき配当: PHAは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。

高配当: PHAは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。

株主への利益配当

収益カバレッジ: PHAの配当性向を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。

株主配当金

キャッシュフローカバレッジ: PHAが配当金を報告していないため、配当金の持続可能性を計算できません。

Premier Health of America 配当金

配当金 基準チェック /06

主要情報

最近の配当金アップデート

Recent updates

New major risk - Share price stability

Third quarter 2024 earnings released: CA$0.15 loss per share (vs CA$0.01 profit in 3Q 2023)

Does Premier Health of America (CVE:PHA) Have A Healthy Balance Sheet?

Investors Aren't Entirely Convinced By Premier Health of America Inc.'s (CVE:PHA) Revenues

New minor risk - Share price stability

Price target decreased by 12% to CA$0.95

Second quarter 2024 earnings released: CA$0.028 loss per share (vs CA$0.001 profit in 2Q 2023)

Premier Health of America (CVE:PHA) Has A Somewhat Strained Balance Sheet

Premier Health of America Inc. Announces Chief Technology Officer Changes

First quarter 2024 earnings released: CA$0.004 loss per share (vs CA$0.007 loss in 1Q 2023)

A Piece Of The Puzzle Missing From Premier Health of America Inc.'s (CVE:PHA) 30% Share Price Climb

Price target increased by 13% to CA$1.08

Premier Health of America Inc., Annual General Meeting, Mar 28, 2024

Further Upside For Premier Health of America Inc. (CVE:PHA) Shares Could Introduce Price Risks After 26% Bounce

Full year 2023 earnings released: CA$0.031 loss per share (vs CA$0.002 loss in FY 2022)

Here's Why Premier Health of America (CVE:PHA) Has A Meaningful Debt Burden

Third quarter 2023 earnings released: EPS: CA$0.01 (vs CA$0.007 in 3Q 2022)

New minor risk - Share price stability

Price target increased by 19% to CA$0.95

These 4 Measures Indicate That Premier Health of America (CVE:PHA) Is Using Debt Extensively

New major risk - Market cap size

Second quarter 2023 earnings released: EPS: CA$0.001 (vs CA$0.014 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.006 profit in 1Q 2022)

Premier Health of America Inc., Annual General Meeting, Mar 23, 2023

Premier Health of America Inc. Announces CFO Changes

Full year 2022 earnings released: CA$0.002 loss per share (vs CA$0.03 profit in FY 2021)

Less than half of directors are independent

Premier Health of America Inc. Announces Appointment of Simon Belval as Interim Chief Financial Officer

Third quarter 2022 earnings released: EPS: CA$0.007 (vs CA$0.012 in 3Q 2021)

Does Premier Health of America (CVE:PHA) Have A Healthy Balance Sheet?

VP of Corporate Development & Director exercised options to buy CA$143k worth of stock.

Second quarter 2022 earnings: EPS misses analyst expectations

Price target increased to CA$1.63

Less than half of directors are independent

We Think Premier Health of America (CVE:PHA) Can Stay On Top Of Its Debt

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Premier Health of America Inc. Appoints Pierre-Luc Toupin to the Board of Directors

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Here's Why Premier Health of America (CVE:PHA) Can Manage Its Debt Responsibly

Price target decreased to CA$1.80

Estimating The Intrinsic Value Of Premier Health of America Inc. (CVE:PHA)

Director recently sold CA$315k worth of stock

Investor sentiment deteriorated over the past week

Director recently sold CA$246k worth of stock

Third quarter 2021 earnings released: EPS CA$0.012 (vs CA$0.01 in 3Q 2020)

Investors Shouldn't Be Too Comfortable With Premier Health of America's (CVE:PHA) Robust Earnings

Second quarter 2021 earnings released: EPS CA$0.017 (vs CA$0.049 loss in 2Q 2020)

Price target increased to CA$2.10

Premier Health of America Inc. (TSXV:PHA) acquired Solutions Nursing L.F.C. Inc. and Formation Solutions Nursing Inc. for CAD 2.7 million.

Premier Health Announces $18 Million Paratransit Tender Win from Government of Quebec

First quarter 2021 earnings released: EPS CA$0.017 (vs CA$0.005 in 1Q 2020)

Premier Health of America Inc. has completed a Follow-on Equity Offering in the amount of CAD 6.51 million.

Independent Chairman of the Board recently bought CA$100k worth of stock

Independent Chairman of the Board Eric Chouinard Just Bought 9.4% More Shares In Premier Health of America Inc. (CVE:PHA)

Premier Health of America Inc. Appoints Joseph Cianci to the Board of Directors

These 4 Measures Indicate That Premier Health of America (CVE:PHA) Is Using Debt Reasonably Well

New 90-day high: CA$0.90

Premier Health of America Inc., Annual General Meeting, Feb 17, 2021

New 90-day low: CA$0.50

Premier Health Announces the Appointment of Sylvain Charbonneau as Its New CFO

Premier Health of America Inc. (TSXV:PHA) completed the acquisition of Code Bleu Placement en Santé from Fiducie Familiale Désilets Corriveau and others for CAD 15.2 million.

New 90-day high: CA$0.63

Third quarter earnings released

Premier Health of America Inc. (TSXV:PHA) entered into a share purchase agreement to acquire Code Bleu Placement en Santé for CAD 17 million.

決済の安定と成長

配当利回り対市場

株主への利益配当

株主配当金

高配当企業の発掘

配当金基準チェック /06